Profile data is unavailable for this security.
About the company
Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.
- Revenue in SEK (TTM)0.00
- Net income in SEK-140.00m
- Incorporated1999
- Employees16.00
- LocationProlight Diagnostics AB (publ)Gasverksgatan 3ALUND 222 29SwedenSWE
- Phone+46 46162065
- Websitehttps://www.prolightdiagnostics.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combigene AB | 1.91m | -36.52m | 51.09m | 10.00 | -- | 0.5395 | -- | 26.69 | -1.84 | -1.84 | 0.0967 | 4.78 | 0.0161 | -- | 3.71 | 239,265.00 | -30.66 | -13.00 | -32.33 | -14.58 | -- | -- | -1,908.16 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| Abera Bioscience AB | 0.00 | -7.63m | 59.11m | 6.00 | -- | 6.72 | -- | -- | -0.5213 | -0.5213 | 0.00 | 0.5733 | 0.00 | -- | -- | 0.00 | -73.37 | -79.42 | -98.59 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
| Strategic Partners A/S | 0.00 | -17.72m | 60.86m | 1.00 | -- | 2.06 | -- | -- | -325.75 | -325.75 | 0.00 | 455.65 | 0.00 | -- | -- | 0.00 | -42.26 | -76.08 | -50.77 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -146.94m | 60.96m | 17.00 | -- | 0.3242 | -- | -- | -4.34 | -4.34 | 0.00 | 5.55 | 0.00 | -- | -- | 0.00 | -49.47 | -28.80 | -54.77 | -31.12 | -- | -- | -- | -- | -- | -334.05 | 0.0132 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Spago Nanomedical AB (publ) | 2.03m | -37.51m | 67.55m | 12.00 | -- | 1.64 | -- | 33.36 | -0.2119 | -0.2119 | 0.0086 | 0.1181 | 0.0525 | -- | 20.15 | 155,769.20 | -97.31 | -20.19 | -113.72 | -20.97 | -132.69 | -- | -1,852.59 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | -6.53m | -18.21m | 69.05m | 5.00 | -- | 2.98 | -- | -- | -0.1594 | -0.4121 | -0.0605 | 0.1603 | -0.0864 | -- | -- | -1,305,600.00 | -24.10 | -37.28 | -44.74 | -51.56 | -- | -- | -- | -2,077.34 | -- | -0.439 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Dextech Medical AB | 0.00 | -4.93m | 76.16m | 1.00 | -- | 2.68 | -- | -- | -0.2665 | -0.2665 | 0.00 | 1.54 | 0.00 | -- | -- | 0.00 | -15.57 | -23.30 | -15.93 | -23.93 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.51 | -- | 18.92 | -- |
| Coegin Pharma AB | 0.00 | -26.00m | 99.97m | 1.00 | -- | 3.81 | -- | -- | -2.25 | -2.25 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -111.12 | -122.02 | -119.99 | -154.70 | -- | -- | -- | -28,466.75 | -- | -55.53 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -140.00m | 100.40m | 16.00 | -- | 0.5845 | -- | -- | -0.3853 | -0.3853 | 0.00 | 0.2447 | 0.00 | -- | -- | 0.00 | -66.82 | -- | -89.89 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -13.84 | -- |
| AroCell AB (publ) | 51.58m | -50.57m | 103.20m | -- | -- | 0.7926 | -- | 2.00 | -0.2195 | -0.2195 | 0.2239 | 0.5653 | 0.3083 | 6.53 | 5.54 | -- | -30.22 | -29.25 | -32.55 | -31.37 | 12.55 | -9.85 | -98.04 | -231.19 | 4.52 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Kancera AB | 0.00 | -53.07m | 116.58m | 5.00 | -- | 1.40 | -- | -- | -0.5955 | -0.5955 | 0.00 | 0.6849 | 0.00 | -- | -- | 0.00 | -56.73 | -54.82 | -66.40 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Sprint Bioscience AB | 60.25m | -19.11m | 119.95m | 36.00 | -- | 8.90 | -- | 1.99 | -0.2737 | -0.2737 | 0.863 | 0.1931 | 1.10 | -- | 7.28 | 2,151,857.00 | -34.81 | -71.22 | -82.55 | -113.71 | 58.54 | 62.75 | -31.72 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Lumito AB (publ) | 17.00k | -31.86m | 128.53m | 13.00 | -- | 1.33 | -- | 7,560.61 | -0.1472 | -0.1472 | 0.00008 | 0.4133 | 0.0001 | -- | 2.43 | 1,133.33 | -26.73 | -20.77 | -30.85 | -22.38 | 42,235.47 | -- | -187,433.80 | -- | 1.10 | -14.60 | 0.1715 | -- | -- | -- | 4.56 | -- | -- | -- |
| NextCell Pharma AB | 10.66m | -41.96m | 131.56m | -- | -- | 1.95 | -- | 12.34 | -0.8805 | -0.8805 | 0.2239 | 0.9249 | 0.1254 | 55.56 | 5.31 | -- | -49.33 | -35.01 | -55.89 | -37.45 | -247.97 | -304.79 | -393.45 | -468.52 | 6.09 | -- | -- | -- | 5.45 | 42.54 | -5.40 | -- | -27.06 | -- |
| AlzeCure Pharma AB | 0.00 | -35.87m | 144.36m | 11.00 | -- | 3.53 | -- | -- | -0.5371 | -0.5371 | 0.00 | 0.4625 | 0.00 | -- | -- | 0.00 | -75.21 | -52.78 | -89.05 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to Prolight Diagnostics AB (publ)'s reporting currency: Swedish Krona SEK
